Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation.

Banković J, Andrä J, Todorović N, Podolski-Renić A, Milošević Z, Miljković D, Krause J, Ruždijić S, Tanić N, Pešić M.

Exp Cell Res. 2013 Apr 15;319(7):1013-27. doi: 10.1016/j.yexcr.2012.12.017. Epub 2013 Jan 5.

PMID:
23298945
2.

Molecular and cytogenetic changes in multi-drug resistant cancer cells and their influence on new compounds testing.

Podolski-Renić A, Jadranin M, Stanković T, Banković J, Stojković S, Chiourea M, Aljančić I, Vajs V, Tešević V, Ruždijić S, Gagos S, Tanić N, Pešić M.

Cancer Chemother Pharmacol. 2013 Sep;72(3):683-97. doi: 10.1007/s00280-013-2247-1. Epub 2013 Aug 10.

PMID:
23934261
3.

Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.

Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.

Life Sci. 2008 Nov 21;83(21-22):700-8. doi: 10.1016/j.lfs.2008.09.009. Epub 2008 Sep 24.

PMID:
18845169
4.

Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines.

Dačević M, Isaković A, Podolski-Renić A, Isaković AM, Stanković T, Milošević Z, Rakić L, Ruždijić S, Pešić M.

PLoS One. 2013;8(1):e54044. doi: 10.1371/journal.pone.0054044. Epub 2013 Jan 11.

5.

Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.

Gayet L, Dayan G, Barakat S, Labialle S, Michaud M, Cogne S, Mazane A, Coleman AW, Rigal D, Baggetto LG.

Biochemistry. 2005 Mar 22;44(11):4499-509.

PMID:
15766280
6.

Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.

Arora A, Seth K, Kalra N, Shukla Y.

Toxicol Appl Pharmacol. 2005 Feb 1;202(3):237-43.

PMID:
15667829
7.

Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.

Yun UJ, Lee JH, Koo KH, Ye SK, Kim SY, Lee CH, Kim YN.

Biochem Pharmacol. 2013 May 15;85(10):1441-53. doi: 10.1016/j.bcp.2013.02.025. Epub 2013 Mar 6.

PMID:
23473805
8.

Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.

Chen Q, Zhou J, Jiang C, Chen J.

J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):326-31. doi: 10.1007/s11596-010-0351-6. Epub 2010 Jun 17.

PMID:
20556576
9.

Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

Bansal T, Jaggi M, Khar RK, Talegaonkar S.

J Pharm Pharm Sci. 2009;12(1):46-78.

10.

P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma.

Savas B, Cole SP, Tsuruo T, Pross HF.

J Clin Immunol. 1996 Nov;16(6):348-57.

PMID:
8946280
11.

Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.

Shekari F, Sadeghpour H, Javidnia K, Saso L, Nazari F, Firuzi O, Miri R.

Eur J Pharmacol. 2015 Jan 5;746:233-44. doi: 10.1016/j.ejphar.2014.10.058. Epub 2014 Nov 14.

PMID:
25445037
12.

Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.

Li J, Xu LZ, He KL, Guo WJ, Zheng YH, Xia P, Chen Y.

Breast Cancer Res. 2001;3(4):253-63. Epub 2001 Apr 2.

13.

Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid.

Majumder S, Dutta P, Mukherjee P, Datta ER, Efferth T, Bhattacharya S, Choudhuri SK.

Cancer Lett. 2006 Nov 28;244(1):16-23. Epub 2006 Jan 10.

PMID:
16410038
14.
15.

Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR.

Shen J, Wang Q, Hu Q, Li Y, Tang G, Chu PK.

Biomaterials. 2014 Oct;35(30):8621-34. doi: 10.1016/j.biomaterials.2014.06.035. Epub 2014 Jul 4.

PMID:
25002258
16.

Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.

Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.

J Pharm Pharmacol. 2004 Aug;56(8):1061-6.

PMID:
15285852
17.
18.

Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.

Abraham I, Jain S, Wu CP, Khanfar MA, Kuang Y, Dai CL, Shi Z, Chen X, Fu L, Ambudkar SV, El Sayed K, Chen ZS.

Biochem Pharmacol. 2010 Nov 15;80(10):1497-506. doi: 10.1016/j.bcp.2010.08.001. Epub 2010 Aug 7.

19.

A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.

Shi R, Li W, Zhang X, Zhang Y, Peng H, Xie Y, Fan D, Liu R, Liu X, Xiong D.

Eur J Pharmacol. 2011 Nov 1;669(1-3):38-44. doi: 10.1016/j.ejphar.2011.07.047. Epub 2011 Aug 19.

PMID:
21871878

Supplemental Content

Support Center